192 related articles for article (PubMed ID: 30228286)
21. Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.
Huang XQ; Zhang XF; Xia JH; Chao J; Pan QZ; Zhao JJ; Zhou ZQ; Chen CL; Tang Y; Weng DS; Zhang JH; Xia JC
Chin J Cancer; 2017 Sep; 36(1):77. PubMed ID: 28950898
[TBL] [Abstract][Full Text] [Related]
22. S-adenosylhomocysteine Hydrolase Participates in DNA Methylation Inheritance.
Ponnaluri VKC; Estève PO; Ruse CI; Pradhan S
J Mol Biol; 2018 Jul; 430(14):2051-2065. PubMed ID: 29758262
[TBL] [Abstract][Full Text] [Related]
23. Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma.
He L; Yang X; Cao X; Liu F; Quan M; Cao J
Oncol Rep; 2013 Jan; 29(1):103-8. PubMed ID: 23064420
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis.
Yu G; Lin J; Liu C; Hou K; Liang M; Shi B
Sci Rep; 2017 Dec; 7(1):17176. PubMed ID: 29214989
[TBL] [Abstract][Full Text] [Related]
25. Human S-adenosylhomocysteine hydrolase: common gene sequence variation and functional genomic characterization.
Feng Q; Keshtgarpour M; Pelleymounter LL; Moon I; Kalari KR; Eckloff BW; Wieben ED; Weinshilboum RM
J Neurochem; 2009 Sep; 110(6):1806-17. PubMed ID: 19619139
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of COBRA1 decreases the proliferation and migration of hepatocellular carcinoma cells.
El Zeneini E; Kamel S; El-Meteini M; Amleh A
Oncol Rep; 2017 Mar; 37(3):1896-1906. PubMed ID: 28112367
[TBL] [Abstract][Full Text] [Related]
27. The IRBIT domain adds new functions to the AHCY family.
Devogelaere B; Sammels E; De Smedt H
Bioessays; 2008 Jul; 30(7):642-52. PubMed ID: 18536033
[TBL] [Abstract][Full Text] [Related]
28. Suppression of CUGBP1 inhibits growth of hepatocellular carcinoma cells.
Liu Y; Huang H; Yuan B; Luo T; Li J; Qin X
Clin Invest Med; 2014 Feb; 37(1):E10-8. PubMed ID: 24502807
[TBL] [Abstract][Full Text] [Related]
29. A novel role of the tumor suppressor GNMT in cellular defense against DNA damage.
Wang YC; Lin WL; Lin YJ; Tang FY; Chen YM; Chiang EP
Int J Cancer; 2014 Feb; 134(4):799-810. PubMed ID: 23922098
[TBL] [Abstract][Full Text] [Related]
30. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
Zhang M; Li Q; Zhang L; Wang Y; Wang L; Li Q; He T; Wan B; Wang X
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):73-79. PubMed ID: 29729697
[TBL] [Abstract][Full Text] [Related]
31. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.
Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T
Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251
[TBL] [Abstract][Full Text] [Related]
32. Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.
Gnani D; Romito I; Artuso S; Chierici M; De Stefanis C; Panera N; Crudele A; Ceccarelli S; Carcarino E; D'Oria V; Porru M; Giorda E; Ferrari K; Miele L; Villa E; Balsano C; Pasini D; Furlanello C; Locatelli F; Nobili V; Rota R; Leonetti C; Alisi A
Cell Death Differ; 2017 May; 24(5):889-902. PubMed ID: 28338656
[TBL] [Abstract][Full Text] [Related]
33. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
[TBL] [Abstract][Full Text] [Related]
34. Functional and Pathological Roles of AHCY.
Vizán P; Di Croce L; Aranda S
Front Cell Dev Biol; 2021; 9():654344. PubMed ID: 33869213
[TBL] [Abstract][Full Text] [Related]
35. S-Adenosylhomocysteine hydrolase overexpression in HEK-293 cells: effect on intracellular adenosine levels, cell viability, and DNA methylation.
Hermes M; Osswald H; Riehle R; Piesch C; Kloor D
Cell Physiol Biochem; 2008; 22(1-4):223-36. PubMed ID: 18769049
[TBL] [Abstract][Full Text] [Related]
36. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
Jin L; He Y; Tang S; Huang S
J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
[TBL] [Abstract][Full Text] [Related]
37. Rock2 regulates Cdc25A through ubiquitin proteasome system in hepatocellular carcinoma cells.
Liu T; Yu X; Li G; Yuan R; Wang Q; Tang P; Wu L; Liu X; Peng X; Shao J
Exp Cell Res; 2012 Oct; 318(16):1994-2003. PubMed ID: 22705122
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of FOXP1 Inhibits Cell Proliferation in Hepatocellular Carcinoma by Inducing G1/S Phase Cell Cycle Arrest.
Wang X; Sun J; Cui M; Zhao F; Ge C; Chen T; Yao M; Li J
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618020
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of CIP2A attenuates tumor progression by inducing cell cycle arrest and promoting cellular senescence in hepatocellular carcinoma.
Yang X; Qu K; Tao J; Yin G; Han S; Liu Q; Sun H
Biochem Biophys Res Commun; 2018 Jan; 495(2):1807-1814. PubMed ID: 29175329
[TBL] [Abstract][Full Text] [Related]
40. Kinetic properties of the common electrophoretic variants of human S-adenosylhomocysteine hydrolase (AHCY): the effect of four nucleoside analogue inhibitors.
Corbo RM; Ingianna R; Scacchi R; Bozzi A
Ann Hum Genet; 1992 Jan; 56(1):35-43. PubMed ID: 1586132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
